Table 4.
CS-LPs | LPs Size (nm) | DLE (%) |
DR (%) |
Mw/DD of CS |
ZP (mV) | Ref. |
---|---|---|---|---|---|---|
Curcumin hybrid MCS-LPs |
54.1 ± 2.4 | 8.08 ± 0.18% | 13.1% (after 12 h) 15.5% (after 24 h) |
CMCS Mw 10 kDa DD 85% |
26.3 ± 2.3 | [73] |
Glutathion/Ferulic acid CS-LPs | 460.3 ± 6.0 | Gluthation: 61.32 ± 1.32; Ferrulic acid: 68.92 ± 1.27 |
- | CS LMw 100 kDa DD ≥ 95% |
57.7 ± 1.3 | [75] |
N acetyl Cys CS-LPs (DPPG 5% CS: lipid ratio 1:1) | 610.08 ± 8.3 | 74 ± 1.73% | 38% (after 7 h) | CS Mw 110–150 kDa DD ≤ 40% |
38.1 ± 0.9 | [72] |
Acteoside CS-LPs | 92.77 ± 2.99 | 88.10 ± 5.36% | 54.82% (after 4 h) 67.34% (after 8 h) |
CS LMw 100 kDa DD ≥ 95% |
19.65 ± 0.9 | [74] |
Triamcinolone acetonide CS-LPs |
100.3 ± 6.8 | 98 ± 5.36% | - | CS LMw 100 kDa DD * |
31.2 ± 0.8 | [81] |
Curcumin thiolated CS-LPs | 406.0 ± 12.0 | 93.95 ± 3.94% | 40.39% (pH 5.5, after 12 h); 24.93% (pH 7.4, after 12 h) |
CS MMw, DD 78% |
36.6 ± 0.6 | [76] |
* unspecified.